Friday, December 5, 2025
Search

WD-40 Company And 5 Other Stocks Have Very High Payout Ratio

Via News Editorial Team

September 15, 2022

WD-40 Company And 5 Other Stocks Have Very High Payout Ratio

(VIANEWS) - Banco Santander Brasil (BSBR), Koninklijke Philips (PHG), WD-40 Company (WDFC) are the highest payout ratio stocks on this list.

Here's the data we've collected of stocks with a high payout ratio up until now. The payout ratio in itself isn't a promise of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. Banco Santander Brasil (BSBR)

171.23% Payout Ratio

Banco Santander (Brasil), S.A. and its subsidiaries offer a variety of banking products and services for individuals, small- and medium businesses, as well as corporate clients in Brazil. It operates two business segments: Global Wholesale Banking and Commercial Banking. The company offers bank deposits, digital prepaid solutions and payment platforms, loyalty programs, employee benefit vouchers, payroll loans and digital debt renegotiation and services, mortgages, home equity financing products, consumer credit, local loans and commercial and trade finance. The company also offers financial advisory and funding services in relation to the origination and distribution fixed-income securities in debt capital markets. It can finance acquisitions and syndicated loan financing, as well as subordinated debt, energy efficiency transactions, mortgages; home equity financing products; consumer credit; stock brokerage, advisory, equity and equity research services. The company also offers investment products, including derivatives and foreign currency, to institutional investors as well as corporate and retail clients. It provides market-making services. It also offers instant payment services, a range of services that are focused on the agricultural sector, microfinance, and online auto listing. It also provides financial products and services to customers via a multichannel distribution network that includes branches, mini-branches and ATMs as well as call centers, Internet banking and mobile banking. Banco Santander (Brasil), S.A., was established in 1985. It is located in Sao Paulo in Brazil.

Volume

Today's last reported volume for Banco Santander Brasil is 352288, 73.08% below its average volume of 1308700.

According to Morningstar, Inc., the next dividend payment is on Apr 21, 2022, the estimated forward annual dividend rate is 0.73 and the estimated forward annual dividend yield is 13.31%.

Banco Santander Brasil's sales growth this year is anticipated to be negative 0.8% and 9.2% for next year.

Year-on-year quarterly revenue growth declined by 30.5%, now sitting on 41.89B for the twelve trailing months.

Banco Santander Brasil's sales growth for the next quarter is 6.9%. The company's growth estimates for the present quarter and the next is 110% and 110%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.64%.

Banco Santander Brasil's Stock Yearly Top and Bottom Value

Banco Santander Brasil's stock is valued at $5.74 at 14:23 EST, way below its 52-week high of $7.98 and way above its 52-week low of $4.87.

Banco Santander Brasil's Moving Average

Banco Santander Brasil's value is above its 50-day moving average of $5.54 and under its 200-day moving average of $6.14.

2. Koninklijke Philips (PHG)

157.1% Payout Ratio

Koninklijke Philips N.V. is a North American health technology company. The company operates in three segments: Diagnosis & Treatment Businesses and Connected Business. It also has Personal Health Businesses. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also provides emergency and acute care, sleep and respiratory care and electronic medical records and management services. The company also offers power brushes, toothbrush heads and interdental cleaning, teeth whitening, and infant feeding solutions. It also provides male grooming products and solutions. The company has an agreement to promote digital pathology, AI solutions for hospitals, pathology labs, health networks and other healthcare facilities worldwide through a partnership with Ibex Medical Analytics Ltd. and a strategic partnership with NICO.LAB. In May 2013, Koninklijke Philips Electronics N.V. was the company's name. Koninklijke Philips N.V. is an 1891 founded company based in Amsterdam, The Netherlands.

Volume

Today's last reported volume for Koninklijke Philips is 2841460, 41.79% above its average volume of 2003940.

According to Morningstar, Inc., the next dividend payment is on May 11, 2022, the estimated forward annual dividend rate is 0.96 and the estimated forward annual dividend yield is 3.96%.

Koninklijke Philips's sales growth this year is anticipated to be negative 5.4% and 6.7% for next year.

Year-on-year quarterly revenue growth grew by 2.4%, now sitting on 17.25B for the twelve trailing months.

Volatility

Koninklijke Philips's last day, week, and month's current intraday variation average was 2.37%, 3.06%, and 2.13%, respectively.

Koninklijke Philips's highest amplitude of average volatility was 1.16% (day), 1.91% (last week), and 2.18% (last month), respectively.

Koninklijke Philips's Stock Yearly Top and Bottom Value

Koninklijke Philips's stock is valued at $17.65 at 14:23 EST, way below its 52-week low of $20.20.

Koninklijke Philips's Moving Average

Koninklijke Philips's value is way under its 50-day moving average of $24.34 and way below its 200-day moving average of $34.00.

3. WD-40 Company (WDFC)

67.72% Payout Ratio

The WD-40 Company is a manufacturer and distributor of maintenance and cleaning products. It has operations in North America, Europe, Asia-Pacific, Africa, Europe, Middle East and Africa. The company sells multi-purpose products such as aerosol sprays and non-aerosol triggers sprays. It also offers liquid-bulk products under WD-40 Multi Use brand for various industrial uses. Specialty maintenance products include penetrants and degreasers as well as greases and lubricants under the WD-40 specialist brand. The company also offers multi-purpose oils and specialty spray oils as well as spray lubricant and other specialty products under the 3-IN-1 brand. Professional spray maintenance products as well as lubricants and lubricants to the bicycle market are available under the GT85 name. The company also offers automated toilet bowl cleaners with the 2000 Flushes name, aerosol and liquid trigger carpet stain/odor eliminators under Spot Shot brands, room and rug cleaners and carpet cleaners under Carpet Fresh; household and carpet cleaners as well as rug and area deodorizers as part of the 1001 brand. In the United States, it sells heavy-duty hand cleaning products under Lava and Solvol names in Australia. The company sells products through warehouse clubs, hardware shops, auto parts outlets, industrial distributors, suppliers, industrial distributors, wholesalers, home centers, value retailers and online retailers. WD-40 Company is a California-based company that was established in 1953.

Volume

Today's last reported volume for WD-40 Company is 66115, 38.15% below its average volume of 106896.

As stated by Morningstar, Inc., the next dividend payment is on Jul 13, 2022, the estimated forward annual dividend rate is 3.12 and the estimated forward annual dividend yield is 1.65%.

WD-40 Company's sales growth this year is anticipated to be 6.9% and 5.6% for next year.

Year-on-year quarterly revenue growth declined by 9.3%, now sitting on 503.64M for the twelve trailing months.

WD-40 Company's sales growth for the current quarter is 13.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.64%.

Volatility

WD-40 Company's last day, week, and month's current intraday variation average was 3.17%, 0.89%, and 1.67%, respectively.

WD-40 Company's highest amplitude of average volatility was 5.89% (day), 2.92% (last week), and 2.70% (last month), respectively.

WD-40 Company's Stock Yearly Top and Bottom Value

WD-40 Company's stock is valued at $183.36 at 14:23 EST, way under its 52-week high of $255.31 and way above its 52-week low of $163.61.

WD-40 Company's Moving Average

WD-40 Company's value is under its 50-day moving average of $188.64 and under its 200-day moving average of $202.91.

4. Xcel Energy (XEL)

62.79% Payout Ratio

Through its subsidiaries, Xcel Energy Inc. generates and transmits, distributes and sells electricity. Regulated Electric Utility and Regulated Natural Gas Utility are its segments. It generates electricity from coal, nuclear and natural gas as well as hydroelectric, renewable, fossil, wind, biomass, oil, and wood/refuse. The company also buys, transports and distributes natural gas for retail customers. It also transports customer-owned gas. The company also develops and leases natural-gas pipelines, storage and compression units, and invests into rental housing projects. It also procures equipment to construct renewable energy facilities. The company serves commercial and residential customers as well as industrial ones in Colorado, Michigan and Minnesota. It sells electricity to around 3.7 million customers and natural gas to about 2.1 million. Xcel Energy Inc. is a Minnesota-based company that was founded in 1909.

Volume

Today's last reported volume for Xcel Energy is 1398690, 48.87% below its average volume of 2735800.

As stated by Morningstar, Inc., the next dividend payment is on Jun 13, 2022, the estimated forward annual dividend rate is 1.95 and the estimated forward annual dividend yield is 2.66%.

Xcel Energy's sales growth this year is expected to be 2.6% and 2.4% for next year.

Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 14B for the twelve trailing months.

Xcel Energy's sales growth is 2.3% for the ongoing quarter and negative 4.8% for the next. The company's growth estimates for the current quarter and the next is 10.6% and 6.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.61%.

Volatility

Xcel Energy's last day, week, and month's current intraday variation average was 0.31%, 1.48%, and 1.20%, respectively.

Xcel Energy's highest amplitude of average volatility was 1.49% (day), 2.03% (last week), and 1.96% (last month), respectively.

Xcel Energy's Stock Yearly Top and Bottom Value

Xcel Energy's stock is valued at $73.56 at 14:23 EST, under its 52-week high of $77.53 and way above its 52-week low of $61.16.

Xcel Energy's Moving Average

Xcel Energy's worth is higher than its 50-day moving average of $73.07 and above its 200-day moving average of $70.75.

5. Cohen & Steers Limited Duration (LDP)

35.09% Payout Ratio

Cohen & Steers Limited Duration Preferred Income Fund, Inc., is a closed-ended fixed-income fund that was launched by Cohen & Steers, Inc. Cohen & Steers Capital Management, Inc. manages the fund. The fund invests in fixed-income markets around the world. It uses interest rate swaps and derivatives for its investment. The fund seeks companies operating in all financial sector, including banking, diversified financials and real estate. The fund primarily invests in floating-rate and fixed-to-floating-rate preferred securities, preferred securities, traditional preferred securities, hybrid-preferred securities, debt securities, and convertible securities. To create its portfolio, it uses fundamental analysis with an emphasis on the creditworthiness of issuers and current market factors. It benchmarks its portfolio performance against the BofA Merrill Lynch Capital Securities Index, a composite benchmark that includes 75% BofA Merrill Lynch Capital Securities Index as well as 25% BofA Merrill Lynch Constrained Adjustable Ratio Preferred Securities Index. Cohen & Steers Limited Duration Preferred Income Fund, Inc. was established on May 1, 2012. It is domiciled at the United States.

Volume

Today's last reported volume for Cohen & Steers Limited Duration is 42240, 48.91% below its average volume of 82690.

According to Morningstar, Inc., the next dividend payment is on Mar 14, 2022, the estimated forward annual dividend rate is 1.62 and the estimated forward annual dividend yield is 7.27%.

Volatility

Cohen & Steers Limited Duration's last day, week, and month's current intraday variation average was 0.05%, 0.38%, and 0.65%, respectively.

Cohen & Steers Limited Duration's highest amplitude of average volatility was 1.00% (day), 1.25% (last week), and 1.59% (last month), respectively.

Cohen & Steers Limited Duration's Stock Yearly Top and Bottom Value

Cohen & Steers Limited Duration's stock is valued at $19.96 at 14:23 EST, way below its 52-week high of $27.70 and higher than its 52-week low of $18.82.

Cohen & Steers Limited Duration's Moving Average

Cohen & Steers Limited Duration's value is under its 50-day moving average of $20.58 and way below its 200-day moving average of $22.42.

6. Novartis AG (NVS)

31.05% Payout Ratio

Novartis AG develops and manufactures healthcare products around the world. Two segments of the company are Innovative Medicines (Sandoz) and Healthcare Products. Innovative Medicines offers prescription medications for both patients and health care providers. The company also offers ophthalmology and neuroscience as well as immunology, dermatology, neurology, immunology, and metabolism medicines products. Sandoz produces, markets, and manufactures finished dosage form medications; active ingredients, as well as finished dosage forms, of small-molecule pharmaceuticals for third parties. It also sells generics and antiinfectives. The company also supplies active pharmaceutical ingredients, intermediates, mainly antibiotics; proteins- or other biotechnology based products; and services in biotechnology manufacturing. Novartis AG holds a collaboration and license agreement with Alnylam Pharmaceuticals for the development, manufacturing, and marketing of inclisiran. Kura Oncology, Inc. has been contracted to conduct clinical trials to assess the combined effect of Tipifarnib/Alpelisib on patients suffering from head and neck carcinoma. Basel is the headquarters of this company, which was founded in 1996.

Volume

Today's last reported volume for Novartis AG is 915350, 57.35% below its average volume of 2146610.

As stated by Morningstar, Inc., the next dividend payment is on Mar 7, 2022, the estimated forward annual dividend rate is 3.33 and the estimated forward annual dividend yield is 3.87%.

Novartis AG's sales growth this year is expected to be 3% and 3.1% for next year.

Year-on-year quarterly revenue growth grew by 0.9%, now sitting on 53B for the twelve trailing months.

Novartis AG's sales growth for the next quarter is 3.1%. The company's growth estimates for the present quarter and the next is negative 7.8% and negative -7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 43.06%.

Volatility

Novartis AG's last day, week, and month's current intraday variation average was 1.29%, 1.49%, and 0.89%, respectively.

Novartis AG's highest amplitude of average volatility was 1.49% (day), 1.21% (last week), and 1.44% (last month), respectively.

Novartis AG's Stock Yearly Top and Bottom Value

Novartis AG's stock is valued at $81.03 at 14:23 EST, way under its 52-week high of $95.17 and above its 52-week low of $79.09.

Novartis AG's Moving Average

Novartis AG's value is below its 50-day moving average of $86.78 and below its 200-day moving average of $85.59.